Αποτελέσματα Αναζήτησης
26 Σεπ 2023 · This study looks to prospectively evaluate the effects of “triple therapy” with dexamethasone, octreotide, and metoclopramide in the nonoperative management of malignant small bowel obstruction, specifically evaluating the regimen for deobstruction or resolution of the obstruction and secondary evaluation of resumption of oral intake and ...
31 Μαΐ 2022 · This review is therefore conducted to identify the causes and treatments reported in the literature to inform the practitioners to consider different causes of nasal obstruction when making the diagnosis and choose the most effective and safe treatment for their patients.
20 Απρ 2017 · However, high-dose regimens and long-term use of ICS may be associated with a variety of side effects, similar to those observed with systemic corticosteroid therapy. These side effects include impaired growth in children, osteoporosis, fractures, glaucoma, cataracts, and skin thinning.
26 Σεπ 2018 · Diarrhea is an expected and manageable side effect from some cytotoxic and targeted agents. While constipation can be severe from analgesics, thalidomide, lenalidomide, and vinca alkaloids, management may vary depending upon anatomical considerations.
27 Ιουν 2024 · Nevertheless constipation is a common side effect. Antipsychotic agents differ in their liability to induce constipation. Constipation can be severe and can lead to serious consequences such as paralytic ileus, bowel occlusion and death. Active screening, monitoring and treatment are recommended.
24 Ιουλ 2023 · Acute Colonic Pseudo-obstruction (ACPO) is a cause of large intestinal dilation and obstruction without any physical transition point. It remains difficult to diagnose and treat. We review the recent updates on diagnosis and management of ACPO.
13 Μαΐ 2021 · 1. Introduction. Anticholinergic drugs are frequently prescribed for several indications: overactive bladder, gastrointestinal disorders, and bradycardia. Moreover, many drugs not recognized as anticholinergics, such as antidepressants, bronchodilators, skeletal muscle relaxants, and antispasmodics, often show anticholinergic activity.
